Skip to Main Content
Back to News

Insider Sale: Director at $CYTK Sells 6,757 Shares

Automated

Edward M. MD Kaye, a director at $CYTK, sold 6,757 shares of the company on 10-06-2025 for an estimated $405,420. We received data on the trade from a recent SEC filing. This was a sale of approximately 40.9% of their shares of this class of stock. Following this trade, they now own 9,778 shares of this class of $CYTK stock.

$CYTK Insider Trading Activity

CYTK Insider Trades

$CYTK insiders have traded $CYTK stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.

Here’s a breakdown of recent trading of $CYTK stock by insiders over the last 6 months:

  • ROBERT I BLUM (President & CEO) has made 0 purchases and 12 sales selling 60,000 shares for an estimated $2,369,150.
  • EDWARD M. MD KAYE has made 0 purchases and 4 sales selling 23,844 shares for an estimated $1,228,696.
  • FADY IBRAHAM MALIK (EVP Research & Development) has made 0 purchases and 12 sales selling 24,000 shares for an estimated $905,040.
  • WENDALL WIERENGA sold 20,000 shares for an estimated $769,200
  • ANDREW CALLOS (EVP, Chief Commercial Officer) has made 0 purchases and 3 sales selling 15,547 shares for an estimated $527,488.
  • JOHN T HENDERSON sold 3,190 shares for an estimated $123,325
  • ROBERT ARTHUR HARRINGTON sold 2,150 shares for an estimated $104,640
  • MUNA BHANJI sold 1,454 shares for an estimated $43,227

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CYTK Hedge Fund Activity

We have seen 168 institutional investors add shares of $CYTK stock to their portfolio, and 170 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CYTK Congressional Stock Trading

Members of Congress have traded $CYTK stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CYTK stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CYTK Analyst Ratings

Wall Street analysts have issued reports on $CYTK in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 10/06/2025
  • HC Wainwright & Co. issued a "Buy" rating on 09/29/2025
  • Needham issued a "Buy" rating on 09/02/2025
  • JMP Securities issued a "Market Outperform" rating on 09/02/2025
  • Stifel issued a "Buy" rating on 09/02/2025
  • Citigroup issued a "Buy" rating on 09/02/2025
  • JP Morgan issued a "Overweight" rating on 06/09/2025

To track analyst ratings and price targets for $CYTK, check out Quiver Quantitative's $CYTK forecast page.

$CYTK Price Targets

Multiple analysts have issued price targets for $CYTK recently. We have seen 14 analysts offer price targets for $CYTK in the last 6 months, with a median target of $80.0.

Here are some recent targets:

  • Gena Wang from Barclays set a target price of $82.0 on 10/06/2025
  • Jason Zemansky from B of A Securities set a target price of $56.0 on 10/02/2025
  • Joseph Pantginis from HC Wainwright & Co. set a target price of $120.0 on 09/29/2025
  • Mayank Mamtani from B. Riley Securities set a target price of $80.0 on 09/22/2025
  • Cory Kasimov from Evercore ISI Group set a target price of $80.0 on 09/03/2025
  • Jason N. Butler from JMP Securities set a target price of $78.0 on 09/02/2025
  • James Condulis from Stifel set a target price of $96.0 on 09/02/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles